Vesicular Monoamine Transporter 2 Inhibitor

DrugDrug NameDrug Indication
DB04844TetrabenazineTreatment of hyperkinetic movement disorders like chorea in Huntington's disease, hemiballismus, senile chorea, Tourette syndrome and other tic disorders, and tardive dyskinesia
DB11915ValbenazineFor the treatment of tardive dyskinesia in adults [FDA Label].